Class IITerminatedD-0913-2023
Drug recall · July 19, 2023
Sunitinib Malate Capsules recall
Why: Failed Moisture Limits: Water (moisture) content above the approved product specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28
- Lots / codes
Lot # 100037220, Exp 10/2024
- Quantity
- 180 bottles
- Company
- Teva Pharmaceuticals USA Inc, Parsippany, NJ
- Distribution
- Product was distributed to 3 wholesalers/distributors who further distributed the product Nationwide in the USA.
- Initiated
- July 5, 2023 · Voluntary: Firm initiated
- Classified
- July 11, 2023
- Reported
- July 19, 2023
- Ended
- January 10, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.